Cobalamin as a regulator of serum and cerebrospinal fluid levels of normal prions

Giuseppe Scalabrino, Daniela Veber, Chiara Briani, Silvano Milani, Antonietta Terralavoro, Sergio Brenna, Luca Valenti, Vincenzo Silani, Claudia Morelli, Maddalena Peracchi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

We have previously demonstrated that the concentration of normal prion proteins (PrPC) is increased in the serum and cerebrospinal fluid (CSF) of rats deficient in vitamin B12 (cobalamin, Cbl). In this study, we investigated whether similar increases also occur in the serum and CSF of patients deficient in Cbl (Cbl-D), and whether the increase in serum levels can be corrected by Cbl therapy. The study involved two sample populations. The first consisted of 45 patients (13 patients with pernicious anemia [PA], 19 with other forms of anemia, and 13 healthy controls); and the second, 68 patients (five with subacute combined degeneration [SCD], 18 with amyotrophic lateral sclerosis, 22 with multiple sclerosis [MS], and 23 neurological controls). Serum PrPC levels were measured using an enzyme-linked-immunosorbent-assay before as well as after Cbl therapy. The mean serum PrPC levels in patients with PA were significantly higher than those of the controls (p = 0.0017) but normalized after Cbl therapy; there was no significant change in the patients with other forms of anemia. Mean CSF PrPC levels in the patients with SCD were significantly higher than in the neurological controls (p <0.03). The serum and CSF PrPC levels of patients with PA and those with SCD were correlated significantly with serum (p = 0.004) and CSF (p = 0.0018) Cbl levels. In patients with MS, CSF PrPC concentrations were significantly lower than those of the controls regardless of their CSF Cbl levels. We found a correlation between Cbl and PrPC levels in the serum and CSF of Cbl-D patients, which suggests that Cbl may regulate the PrPC levels in the serum and CSF in humans.

Original languageEnglish
Pages (from-to)134-138
Number of pages5
JournalJournal of Clinical Neuroscience
Volume20
Issue number1
DOIs
Publication statusPublished - Jan 2013

Fingerprint

Prions
Vitamin B 12
Cerebrospinal Fluid
Serum
Subacute Combined Degeneration
Pernicious Anemia
Multiple Sclerosis
Anemia
Amyotrophic Lateral Sclerosis
Therapeutics
Enzyme-Linked Immunosorbent Assay

Keywords

  • Cerebrospinal fluid
  • Cobalamin deficiency
  • Multiple sclerosis
  • Normal prions
  • Pernicious anemia
  • Subacute combined degeneration

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Physiology (medical)

Cite this

Scalabrino, G., Veber, D., Briani, C., Milani, S., Terralavoro, A., Brenna, S., ... Peracchi, M. (2013). Cobalamin as a regulator of serum and cerebrospinal fluid levels of normal prions. Journal of Clinical Neuroscience, 20(1), 134-138. https://doi.org/10.1016/j.jocn.2012.08.004

Cobalamin as a regulator of serum and cerebrospinal fluid levels of normal prions. / Scalabrino, Giuseppe; Veber, Daniela; Briani, Chiara; Milani, Silvano; Terralavoro, Antonietta; Brenna, Sergio; Valenti, Luca; Silani, Vincenzo; Morelli, Claudia; Peracchi, Maddalena.

In: Journal of Clinical Neuroscience, Vol. 20, No. 1, 01.2013, p. 134-138.

Research output: Contribution to journalArticle

Scalabrino, G, Veber, D, Briani, C, Milani, S, Terralavoro, A, Brenna, S, Valenti, L, Silani, V, Morelli, C & Peracchi, M 2013, 'Cobalamin as a regulator of serum and cerebrospinal fluid levels of normal prions', Journal of Clinical Neuroscience, vol. 20, no. 1, pp. 134-138. https://doi.org/10.1016/j.jocn.2012.08.004
Scalabrino, Giuseppe ; Veber, Daniela ; Briani, Chiara ; Milani, Silvano ; Terralavoro, Antonietta ; Brenna, Sergio ; Valenti, Luca ; Silani, Vincenzo ; Morelli, Claudia ; Peracchi, Maddalena. / Cobalamin as a regulator of serum and cerebrospinal fluid levels of normal prions. In: Journal of Clinical Neuroscience. 2013 ; Vol. 20, No. 1. pp. 134-138.
@article{e45f89253fef4b3e80c743d51f6f0ad9,
title = "Cobalamin as a regulator of serum and cerebrospinal fluid levels of normal prions",
abstract = "We have previously demonstrated that the concentration of normal prion proteins (PrPC) is increased in the serum and cerebrospinal fluid (CSF) of rats deficient in vitamin B12 (cobalamin, Cbl). In this study, we investigated whether similar increases also occur in the serum and CSF of patients deficient in Cbl (Cbl-D), and whether the increase in serum levels can be corrected by Cbl therapy. The study involved two sample populations. The first consisted of 45 patients (13 patients with pernicious anemia [PA], 19 with other forms of anemia, and 13 healthy controls); and the second, 68 patients (five with subacute combined degeneration [SCD], 18 with amyotrophic lateral sclerosis, 22 with multiple sclerosis [MS], and 23 neurological controls). Serum PrPC levels were measured using an enzyme-linked-immunosorbent-assay before as well as after Cbl therapy. The mean serum PrPC levels in patients with PA were significantly higher than those of the controls (p = 0.0017) but normalized after Cbl therapy; there was no significant change in the patients with other forms of anemia. Mean CSF PrPC levels in the patients with SCD were significantly higher than in the neurological controls (p <0.03). The serum and CSF PrPC levels of patients with PA and those with SCD were correlated significantly with serum (p = 0.004) and CSF (p = 0.0018) Cbl levels. In patients with MS, CSF PrPC concentrations were significantly lower than those of the controls regardless of their CSF Cbl levels. We found a correlation between Cbl and PrPC levels in the serum and CSF of Cbl-D patients, which suggests that Cbl may regulate the PrPC levels in the serum and CSF in humans.",
keywords = "Cerebrospinal fluid, Cobalamin deficiency, Multiple sclerosis, Normal prions, Pernicious anemia, Subacute combined degeneration",
author = "Giuseppe Scalabrino and Daniela Veber and Chiara Briani and Silvano Milani and Antonietta Terralavoro and Sergio Brenna and Luca Valenti and Vincenzo Silani and Claudia Morelli and Maddalena Peracchi",
year = "2013",
month = "1",
doi = "10.1016/j.jocn.2012.08.004",
language = "English",
volume = "20",
pages = "134--138",
journal = "Journal of Clinical Neuroscience",
issn = "0967-5868",
publisher = "Churchill Livingstone",
number = "1",

}

TY - JOUR

T1 - Cobalamin as a regulator of serum and cerebrospinal fluid levels of normal prions

AU - Scalabrino, Giuseppe

AU - Veber, Daniela

AU - Briani, Chiara

AU - Milani, Silvano

AU - Terralavoro, Antonietta

AU - Brenna, Sergio

AU - Valenti, Luca

AU - Silani, Vincenzo

AU - Morelli, Claudia

AU - Peracchi, Maddalena

PY - 2013/1

Y1 - 2013/1

N2 - We have previously demonstrated that the concentration of normal prion proteins (PrPC) is increased in the serum and cerebrospinal fluid (CSF) of rats deficient in vitamin B12 (cobalamin, Cbl). In this study, we investigated whether similar increases also occur in the serum and CSF of patients deficient in Cbl (Cbl-D), and whether the increase in serum levels can be corrected by Cbl therapy. The study involved two sample populations. The first consisted of 45 patients (13 patients with pernicious anemia [PA], 19 with other forms of anemia, and 13 healthy controls); and the second, 68 patients (five with subacute combined degeneration [SCD], 18 with amyotrophic lateral sclerosis, 22 with multiple sclerosis [MS], and 23 neurological controls). Serum PrPC levels were measured using an enzyme-linked-immunosorbent-assay before as well as after Cbl therapy. The mean serum PrPC levels in patients with PA were significantly higher than those of the controls (p = 0.0017) but normalized after Cbl therapy; there was no significant change in the patients with other forms of anemia. Mean CSF PrPC levels in the patients with SCD were significantly higher than in the neurological controls (p <0.03). The serum and CSF PrPC levels of patients with PA and those with SCD were correlated significantly with serum (p = 0.004) and CSF (p = 0.0018) Cbl levels. In patients with MS, CSF PrPC concentrations were significantly lower than those of the controls regardless of their CSF Cbl levels. We found a correlation between Cbl and PrPC levels in the serum and CSF of Cbl-D patients, which suggests that Cbl may regulate the PrPC levels in the serum and CSF in humans.

AB - We have previously demonstrated that the concentration of normal prion proteins (PrPC) is increased in the serum and cerebrospinal fluid (CSF) of rats deficient in vitamin B12 (cobalamin, Cbl). In this study, we investigated whether similar increases also occur in the serum and CSF of patients deficient in Cbl (Cbl-D), and whether the increase in serum levels can be corrected by Cbl therapy. The study involved two sample populations. The first consisted of 45 patients (13 patients with pernicious anemia [PA], 19 with other forms of anemia, and 13 healthy controls); and the second, 68 patients (five with subacute combined degeneration [SCD], 18 with amyotrophic lateral sclerosis, 22 with multiple sclerosis [MS], and 23 neurological controls). Serum PrPC levels were measured using an enzyme-linked-immunosorbent-assay before as well as after Cbl therapy. The mean serum PrPC levels in patients with PA were significantly higher than those of the controls (p = 0.0017) but normalized after Cbl therapy; there was no significant change in the patients with other forms of anemia. Mean CSF PrPC levels in the patients with SCD were significantly higher than in the neurological controls (p <0.03). The serum and CSF PrPC levels of patients with PA and those with SCD were correlated significantly with serum (p = 0.004) and CSF (p = 0.0018) Cbl levels. In patients with MS, CSF PrPC concentrations were significantly lower than those of the controls regardless of their CSF Cbl levels. We found a correlation between Cbl and PrPC levels in the serum and CSF of Cbl-D patients, which suggests that Cbl may regulate the PrPC levels in the serum and CSF in humans.

KW - Cerebrospinal fluid

KW - Cobalamin deficiency

KW - Multiple sclerosis

KW - Normal prions

KW - Pernicious anemia

KW - Subacute combined degeneration

UR - http://www.scopus.com/inward/record.url?scp=84871417979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871417979&partnerID=8YFLogxK

U2 - 10.1016/j.jocn.2012.08.004

DO - 10.1016/j.jocn.2012.08.004

M3 - Article

C2 - 23146213

AN - SCOPUS:84871417979

VL - 20

SP - 134

EP - 138

JO - Journal of Clinical Neuroscience

JF - Journal of Clinical Neuroscience

SN - 0967-5868

IS - 1

ER -